Results 191 to 200 of about 5,943,244 (298)

A compact, wireless fluorimeter system for continuous, real-time monitoring of tissue perfusion via in vivo fluorescence signals. [PDF]

Sci Adv
Park TW, Zhang H, Park C, Goldstein SD, Wade L, Rytkin E, McLuckie AJ, Kulahci Y, Janarthanan R, Kim TY, Jo MS, Sazoglu B, Demir Z, Dirican O, Demir FE, Maeng WY, Yoo S, Saba P, Zhang K, Ahn HY, Kim JU, Lee J, Banks A, Oh S, Kwon K, Nugent A, Efimov IR, Gorantla VS, Pelech A, Huang Y, Rogers JA.   +30 more
europepmc   +1 more source

Inebilizumab in AQP4‐Seropositive NMOSD: One‐Year Follow‐Up From a Multicenter, Real‐World Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Real‐world evidence on inebilizumab among neuromyelitis optica spectrum disorder (NMOSD) patients is lacking. This study assessed inebilizumab among Chinese patients with aquaporin 4 autoantibody (AQP4‐IgG)‐seropositive NMOSD in a real‐world setting.
Mengcui Gui, Jiayang Zhan, Wei Li, Tao Jin, Dan He, Daishi Tian, Zhijun Li, Jing Lin, Yue Li, Hongyu Zhou, Bitao Bu   +10 more
wiley   +1 more source

Effectiveness of low vision rehabilitation on visual function and quality of life in Sub-Saharan Africa: a systematic review. [PDF]

Front Rehabil Sci
Akuffo KO, Agyekum S, Kyeremeh S, Andoh AKA, Osei Duah Junior I, Boateng JA, Mensah NAO, Acquah EA, Owiredu D, Darrah S, Baidoo DA, Eisenbarth W.   +11 more
europepmc   +1 more source

The Comprehensive Live Cell‐Based Cytotoxicity Assay for Monitoring Disease Activity and Guiding Rescue Therapy in Acute Attacks of NMOSD

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Neuromyelitis optica spectrum disorder (NMOSD) is a devastating neurological disease that lacks serological biomarkers that can accurately reflect disease activity. We established a live cell‐based assay (LCBA) using serum with endogenous complement to quantify the overall cytotoxicity, offering a novel functional tool for monitoring
Xiaona Xu, Jie Ding, Yupeng Du, Guibao Luo, Jinming Li, Rui Liu, Xiaoyi Xu, Xiao Li, Minshu Li, Wei Jiang, Chunsheng Yang   +10 more
wiley   +1 more source

Linear and Nonlinear Optical Properties of an AlSb/InAs/AlSb Spherical Quantum Dot in a Magnetic Field. [PDF]

Nanomaterials (Basel)
Wang S, Dakhlaoui H, Wong BM.
europepmc   +1 more source

Association Between Neurofilament Light Chain and Real‐World Ambulatory Function in Progressive MS

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Neurofilament light chain (NfL) is a biomarker of neuroaxonal injury in multiple sclerosis (MS), yet associations with functional outcomes remain unclear. Longitudinal associations between serum NfL (sNfL) and daily step count (STEPS) from wearable devices were assessed in a large international progressive MS cohort.
Gabby B. Joseph, Megan McCune, Riley Bove, Ahmed Abdelhak, Bruce A. C. Cree, Valerie J. Block   +5 more
wiley   +1 more source

Single-exposure holographic 3D printing via inverse-designed phase masks. [PDF]

Sci Adv
Lin D, Chen X, O'Dea CJ, Kim JW, Mason KS, Groh B, Lee KS, Majumder A, Chang CH, Cullinan M, Page ZA, Menon R.   +11 more
europepmc   +1 more source

Generalized Dystonia With Cervical Predominance in a Patient With a De Novo TCF20 Variant

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT TCF20 has been implicated in developmental delay and intellectual disability, with dystonia reported less frequently. We describe a woman in her early twenties with childhood‐onset learning difficulties, progressive dysarthria, tremor, and generalized dystonia with marked cervical predominance, associated with a de novo TCF20 frameshift ...
Melisa Kilic, Petr Dusek, Ibrahim Kamaci, Bahar Gulmez, Gul Yalcin Cakmakli, Ersin Tan, Sibel Ugur Iseri, Zuhal Yapici   +7 more
wiley   +1 more source

Sol-Gel Process Optimization of Transparent Silica Aerogels: Regulating Nanostructure to Enhance Optical Transmittance. [PDF]

Nanomaterials (Basel)
Hu G, He J, Wu R, Li X, Su Y, Yang B, Wang X, Hu J, Sun W, Yan Y.   +9 more
europepmc   +1 more source

microRNA‐7‐5p and α‐Synuclein SAA Predict Parkinson's Disease Phenoconversion

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Corroborate blood neuron‐derived extracellular vesicle (NDEV) alpha‐synuclein (αSyn), the CSF αSyn seed amplification assay (αSyn‐SAA), and blood microRNA‐7‐5p (miR‐7‐5p) as markers for Parkinson's disease (PD) phenoconversion and determine if combining these markers would help select subjects who would be more likely to phenoconvert.
Shayan Zadegan, Praveen Velammal, Kanmani Muthiah, Madhu Jatty, Christopher Adams   +4 more
wiley   +1 more source